SHCM
PFE icon

Stokes & Hubbell Capital Management’s Pfizer PFE Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$4.11M Sell
102,048
-1,914
-2% -$76.7K 0.86% 34
2018
Q4 		$4.3M Sell
103,962
-196
-0.2% -$8.14K 0.98% 29
2018
Q3 		$4.36M Buy
104,158
+1,413
+1% +$54.4K 0.9% 33
2018
Q2 		$3.54M Buy
102,745
+2,299
+2% +$78.6K 0.8% 36
2018
Q1 		$3.38M Buy
100,446
+6,703
+7% +$230K 0.78% 35
2017
Q4 		$3.22M Sell
93,743
-212
-0.2% -$7.23K 0.78% 35
2017
Q3 		$3.18M Buy
93,955
+36,985
+65% +$1.19M 0.82% 33
2017
Q2 		$1.82M Sell
56,970
-559
-1% -$17.6K 0.56% 44
2017
Q1 		$1.87M Buy
57,529
+2,068
+4% +$65.2K 0.63% 41
2016
Q4 		$1.71M Buy
55,461
+37
+0.1% +$1.13K 0.66% 38
2016
Q3 		$1.78M Buy
55,424
+3,490
+7% +$117K 0.74% 36
2016
Q2 		$1.74M Buy
51,934
+7,103
+16% +$227K 0.75% 35
2016
Q1 		$1.26M Buy
44,831
+21,678
+94% +$619K 0.58% 38
2015
Q4 		$709K Sell
23,153
-263
-1% -$8.27K 0.38% 45
2015
Q3 		$698K Buy
+23,416
New +$751K 0.42% 44

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Stokes & Hubbell Capital Management's PFE Position: Q1 2019 in Review

Stokes & Hubbell Capital Management reduced its Pfizer (PFE) stake by 1.8% in Q1 2019, selling an estimated $76.7K and leaving 102,048 shares worth $4.11M. The position accounts for 0.86% of the portfolio, ranked #34.

Stokes & Hubbell Capital Management first reported a position in PFE in Q3 2015 and has held it in 15 quarters since. The position peaked at $4.36M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Stokes & Hubbell Capital Management held 102,048 shares of Pfizer worth $4.11M as of Q1 2019.
  • Stokes & Hubbell Capital Management sold 1,914 Pfizer shares in Q1 2019, an estimated $76.7K.
  • Pfizer made up 0.86% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #34 holding.
  • Stokes & Hubbell Capital Management first reported a position in Pfizer in Q3 2015 and has held it in 15 quarters since.
  • Stokes & Hubbell Capital Management's Pfizer position peaked at $4.36M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.